Zimmer Biomet (ZBH) is a publicly traded Healthcare sector company. As of July 13, 2026, ZBH trades at $94.01 with a market cap of $17.67B and a P/E ratio of 25.66. ZBH moved +2.55% today. Year to date, ZBH is +0.61%; over the trailing twelve months it is -4.00%. Its 52-week range spans $79.12 to $114.44. Analyst consensus is neutral with an average price target of $97.67. Rallies surfaces ZBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
18 analysts cover ZBH: 0 strong buy, 5 buy, 12 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $97.67.
| Metric | Value |
|---|---|
| Price | $94.01 |
| Market Cap | $17.67B |
| P/E Ratio | 25.66 |
| EPS | $3.56 |
| Dividend Yield | 0.24% |
| 52-Week High | $114.44 |
| 52-Week Low | $79.12 |
| Volume | 219.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $8.23B |
| Net Income | $705.10M |
| Gross Margin | 69.70% |
18 analysts cover ZBH: 0 strong buy, 5 buy, 12 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $97.67.